Clinical trials
Vascular Diseases trials in Italy
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
38 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 3 |
| 2007 | 1 |
| 2008 | 2 |
| 2009 | 3 |
| 2010 | 1 |
| 2011 | 2 |
| 2012 | 2 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 3 |
| 2018 | 2 |
| 2019 | 4 |
| 2020 | 3 |
| 2022 | 1 |
| 2024 | 2 |
| 2025 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 24 |
| Unknown status | 5 |
| Recruiting | 4 |
| Active, not recruiting | 2 |
| Terminated | 2 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Abbott Medical Devices | 6 |
| United Therapeutics | 3 |
| Bayer | 2 |
| Boston Scientific Corporation | 2 |
| Heidelberg University | 2 |
| W.L.Gore & Associates | 2 |
| American Heart of Poland | 1 |
| Azienda Unita Sanitaria Locale di Piacenza | 1 |
| CID - Carbostent & Implantable Devices | 1 |
| Cook Group Incorporated | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Vascular Diseases | 38 |
| Cardiovascular Diseases | 16 |
| Myocardial Ischemia | 11 |
| Coronary Artery Disease | 10 |
| Coronary Stenosis | 8 |
| Heart Diseases | 8 |
| Coronary Disease | 6 |
| Coronary Restenosis | 6 |
| Lung Diseases | 6 |
| Arterial Occlusive Diseases | 5 |
Trials
Showing 1 to 25 of 38. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.